FASN and type 2 diabetes mellitus: The m6A methylase METTL3 in liver tissue of T2DM patients was up-regulated, and METTL3 improved the expression level of fatty acid synthase (FASN) mRNA through m6A modification, which in turn promoted fatty acid metabolism while inhibiting insulin sensitivity of the liver.